Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.
Researchers at Tufts University School of Dental Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have reprogrammed non-healing skin cells from diabetic foot ulcers into pluripotent stem ... Read more
People with a larger waist circumference and higher glucose levels — but not those with abnormal plasma triglyceride, high-density lipoprotein cholesterol (HDL, the good cholesterol), or blood pressure levels — ... Read more
Induced pluripotent stem cells (iPSCs) can be generated from adult cells. Because iPSCs have the potential to develop into any cell type in the human body, they hold an enormous therapeutic potential in ... Read more
Glytec, together with collaborators, presented five abstracts at the American Diabetes Association (ADA)’s 76th Scientific Sessions June 10-14 in New Orleans that focused on diabetes care, particularly in the way Glucommander software ... Read more
Excess weight is an established risk factor for developing type 2 diabetes, yet many obese people don’t develop the condition. Now, researchers at the Karolinska Institute in Sweden and the Institute ... Read more
Gastrointestinal surgeries designed to promote weight loss have been shown to improve glucose homeostasis in patients with type 2 diabetes more efficiently than the standard therapeutic approaches, leading to long-term ... Read more
vTv Therapeutics released promising clinical trial data on two orally administered potential treatments for type 2 diabetes, including one that showed significantly reduced side effects. The data were given in ... Read more